HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 83 filers reported holding HARVARD BIOSCIENCE INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,065,705 | -21.1% | 1,410,629 | +0.7% | 0.06% | -17.3% |
| Q2 2023 | $7,690,551 | +27.2% | 1,400,829 | -2.7% | 0.08% | +23.0% |
| Q1 2023 | $6,044,564 | +53.1% | 1,439,182 | +1.0% | 0.06% | +48.8% |
| Q4 2022 | $3,946,871 | +2.9% | 1,424,863 | -4.9% | 0.04% | -4.7% |
| Q3 2022 | $3,836,000 | -34.2% | 1,498,263 | -7.5% | 0.04% | -28.3% |
| Q2 2022 | $5,833,000 | -44.3% | 1,620,263 | -3.9% | 0.06% | -32.6% |
| Q1 2022 | $10,470,000 | -18.1% | 1,685,963 | -7.0% | 0.09% | -7.3% |
| Q4 2021 | $12,783,000 | +0.7% | 1,813,163 | -0.3% | 0.10% | +1.1% |
| Q3 2021 | $12,692,000 | -24.3% | 1,818,323 | -9.7% | 0.10% | -17.4% |
| Q2 2021 | $16,776,000 | +60.2% | 2,013,950 | +5.0% | 0.12% | +64.3% |
| Q1 2021 | $10,472,000 | +46.6% | 1,917,950 | +15.2% | 0.07% | +18.6% |
| Q4 2020 | $7,145,000 | +48.9% | 1,665,600 | +4.5% | 0.06% | +13.5% |
| Q3 2020 | $4,797,000 | -17.4% | 1,593,725 | -15.0% | 0.05% | -18.8% |
| Q2 2020 | $5,811,000 | +56.4% | 1,874,600 | +11.5% | 0.06% | +25.5% |
| Q1 2020 | $3,715,000 | -26.2% | 1,681,000 | +1.8% | 0.05% | +13.3% |
| Q4 2019 | $5,036,000 | -12.3% | 1,651,000 | -11.6% | 0.04% | -15.1% |
| Q3 2019 | $5,742,000 | +56.9% | 1,867,400 | +2.1% | 0.05% | +60.6% |
| Q2 2019 | $3,660,000 | -50.9% | 1,829,800 | +5.8% | 0.03% | -47.6% |
| Q1 2019 | $7,457,000 | +35.5% | 1,730,200 | 0.0% | 0.06% | +28.6% |
| Q4 2018 | $5,502,000 | -34.5% | 1,730,200 | +8.2% | 0.05% | -15.5% |
| Q3 2018 | $8,398,000 | +0.3% | 1,599,700 | +2.2% | 0.06% | 0.0% |
| Q2 2018 | $8,373,000 | +29.4% | 1,565,000 | +20.9% | 0.06% | +28.9% |
| Q1 2018 | $6,473,000 | +31.0% | 1,294,694 | -13.5% | 0.04% | +36.4% |
| Q4 2017 | $4,940,000 | -15.4% | 1,497,100 | -3.9% | 0.03% | -15.4% |
| Q3 2017 | $5,841,000 | +47.1% | 1,557,600 | 0.0% | 0.04% | +50.0% |
| Q2 2017 | $3,972,000 | -1.9% | 1,557,600 | 0.0% | 0.03% | 0.0% |
| Q1 2017 | $4,050,000 | -12.3% | 1,557,600 | +2.9% | 0.03% | -13.3% |
| Q4 2016 | $4,616,000 | +2.2% | 1,513,600 | -8.9% | 0.03% | 0.0% |
| Q3 2016 | $4,518,000 | +2.2% | 1,661,000 | +7.4% | 0.03% | +3.4% |
| Q2 2016 | $4,422,000 | -5.3% | 1,546,000 | 0.0% | 0.03% | 0.0% |
| Q1 2016 | $4,669,000 | +1.9% | 1,546,000 | +17.0% | 0.03% | +7.4% |
| Q4 2015 | $4,584,000 | -8.2% | 1,321,000 | -0.0% | 0.03% | +3.8% |
| Q3 2015 | $4,996,000 | -33.6% | 1,321,600 | +0.1% | 0.03% | -18.8% |
| Q2 2015 | $7,525,000 | +64.7% | 1,320,200 | +68.2% | 0.03% | +88.2% |
| Q1 2015 | $4,568,000 | +4.0% | 784,800 | +1.3% | 0.02% | +13.3% |
| Q4 2014 | $4,393,000 | +38.6% | 774,800 | 0.0% | 0.02% | +36.4% |
| Q3 2014 | $3,169,000 | -9.2% | 774,800 | +1.0% | 0.01% | +10.0% |
| Q2 2014 | $3,490,000 | -4.0% | 767,100 | 0.0% | 0.01% | -9.1% |
| Q1 2014 | $3,636,000 | +0.9% | 767,100 | 0.0% | 0.01% | +10.0% |
| Q4 2013 | $3,605,000 | -10.7% | 767,100 | 0.0% | 0.01% | -16.7% |
| Q3 2013 | $4,035,000 | +11.2% | 767,100 | 0.0% | 0.01% | +9.1% |
| Q2 2013 | $3,628,000 | – | 767,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |